For the Inventor, By the Inventor

Enter assignee name

Morrisville, NC, United States of America

Liquidia Technologies, Inc.

USPTO Granted Patents = 22

EPO Patents = 5

Trademarks = 4

Forward Citations = 122

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Benjamin Maynor (16 out of 26 patents)

Robert L Henn (10 out of 22 patents)

Jason P Rolland (9 out of 90 patents)

4. Jacob J Sprague (9 out of 9 patents)

5. Brian T Farrer (6 out of 6 patents)

6. Robert Frank Roscigno (6 out of 7 patents)

7. Alexander Ermochkine (3 out of 3 patents)

8. Alex Ermoshkin (3 out of 3 patents)

9. Derek A Schorzman (3 out of 30 patents)

10. Ginger Denison Rothrock (2 out of 30 patents)

11. Kyle Henn (2 out of 2 patents)

12. Lloyd Mahlon Robeson (2 out of 127 patents)

13. Robert Praino (2 out of 2 patents)

14. Andrew J Murphy (1 out of 3 patents)

15. Matthew Craig Parrott (1 out of 11 patents)

22 patents: Sort by Forward Citations

1. 12390475 - Dry powder treprostinil for the treatment of pulmonary hypertension (2025-08-19),

2. 11744836 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-09-05),

3. 11744835 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-09-05),

4. 11712442 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-08-01),

5. 11660304 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-05-30),

6. 10898494 - Dry powder treprostinil for the treatment of pulmonary hypertension (2021-01-26),

7. 10717209 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2020-07-21),

8. 9744715 - Method for producing patterned materials (2017-08-29),

9. 9662809 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2017-05-30),

10. 9545737 - System and method for producing particles and patterned films (2017-01-17),

11. 9340001 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2016-05-17),

12. 9314548 - Nanostructured surfaces for biomedical/biomaterial applications and processes thereof (2016-04-19),

13. 9205594 - Method for producing patterned materials (2015-12-08),

14. 8945527 - Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates (2015-02-03),

15. 8945441 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2015-02-03),

Liquidia Technologies is a biopharmaceutical company that develops and commercializes particle-based vaccines and therapeutics. Their innovative PRINT® technology platform enables precise engineering of particle properties, offering potential benefits for various applications in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Liquidia Technologies, Inc.

22 Patents

#20 in Morrisville, NC

#339 in North Carolina

#15,008 in US

#28,704 in the World

Morrisville, NC, United States of America

Liquidia Technologies, Inc.

Forward Citations = 122

18 inventors:

Benjamin Maynor (16 out of 26 patents)

Robert L Henn (10 out of 22 patents)

Jason P Rolland (9 out of 90 patents)

4. Jacob J Sprague (9 out of 9 patents)

5. Brian T Farrer (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…